Cargando…
Identification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function
The human CMG helicase (Cdc45-MCM-GINS) is a novel target for anti-cancer therapy due to tumor-specific weaknesses in CMG function induced by oncogenic changes and the need for CMG function during recovery from replicative stresses such as chemotherapy. Here, we developed an orthogonal biochemical s...
Autores principales: | Xiang, Shengyan, Luo, Xingju, Welch, Darcy, Reed, Damon R., Alexandrow, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441460/ https://www.ncbi.nlm.nih.gov/pubmed/37609279 http://dx.doi.org/10.21203/rs.3.rs-3182731/v1 |
Ejemplares similares
-
Myc and the Replicative CMG Helicase: The Creation and Destruction of Cancer
por: Reed, Damon R., et al.
Publicado: (2020) -
The eukaryotic CMG helicase pumpjack and integration into the replisome
por: Sun, Jingchuan, et al.
Publicado: (2016) -
Molecular Basis for ATP-Hydrolysis-Driven DNA Translocation by the CMG Helicase of the Eukaryotic Replisome
por: Eickhoff, Patrik, et al.
Publicado: (2019) -
Solving the MCM paradox by visualizing the scaffold of CMG helicase at active replisomes
por: Polasek-Sedlackova, Hana, et al.
Publicado: (2022) -
Tethering of SCF(Dia2) to the Replisome Promotes Efficient Ubiquitylation and Disassembly of the CMG Helicase
por: Maculins, Timurs, et al.
Publicado: (2015)